The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Early Sedation with Dexmedetomidine in Critically Ill Patients
Open accessAbstract
BACKGROUND: Dexmedetomidine produces sedation while maintaining a degree of arousability and may reduce the duration of mechanical ventilation and delirium among patients in the intensive care unit (ICU). The use of dexmedetomidine as the sole or primary sedative agent in patients undergoing mechanical ventilation has not been extensively studied. METHODS: In an open-label, randomized trial, we enrolled critically ill adults who had been undergoing ventilation for less than 12 hours in the ICU and were expected to continue to receive ventilatory support for longer than the next calendar day to receive dexmedetomidine as the sole or primary sedative or to receive usual care (propofol, midazolam, or other sedatives). The target range of sedation-scores on the Richmond Agitation and Sedation Scale (which is scored from -5 [unresponsive] to +4 [combative]) was -2 to +1 (lightly sedated to restless). The primary outcome was the rate of death from any cause at 90 days. RESULTS: We enrolled 4000 patients at a median interval of 4.6 hours between eligibility and randomization. In a modified intention-to-treat analysis involving 3904 patients, the primary outcome event occurred in 566 of 1948 (29.1%) in the dexmedetomidine group and in 569 of 1956 (29.1%) in the usual-care group (adjusted risk difference, 0.0 percentage points; 95% confidence interval, -2.9 to 2.8). An ancillary finding was that to achieve the prescribed level of sedation, patients in the dexmedetomidine group received supplemental propofol (64% of patients), midazolam (3%), or both (7%) during the first 2 days after randomization; in the usual-care group, these drugs were administered as primary sedatives in 60%, 12%, and 20% of the patients, respectively. Bradycardia and hypotension were more common in the dexmedetomidine group. CONCLUSIONS: Among patients undergoing mechanical ventilation in the ICU, those who received early dexmedetomidine for sedation had a rate of death at 90 days similar to that in the usual-care group and required supplemental sedatives to achieve the prescribed level of sedation. More adverse events were reported in the dexmedetomidine group than in the usual-care group. (Funded by the National Health and Medical Research Council of Australia and others; SPICE III ClinicalTrials.gov number, NCT01728558.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., Bonsel, G., & Badia, X. (2011) · Quality of Life Research · doi:10.1007/s11136-011-9903-x · Cited by 9,795
Barr, J., Fraser, G. L., Puntillo, K., Ely, E. W., Gélinas, C., Dasta, J. F., Davidson, J. E., Devlin, J. W., Kress, J. P., Joffe, A. M., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182783b72 · Cited by 3,765
Sessler, C. N., Gosnell, M. S., Grap, M. J., Brophy, G. M., O'Neal, P. V., Keane, K. A., Tesoro, E. P., & Elswick, R. K. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2107138 · Cited by 3,695
Ely, E. W., Inouye, S. K., Bernard, G. R., Gordon, S., Francis, J., May, L., Truman, B., Speroff, T., Gautam, S., Margolin, R., et al. (2001) · JAMA · doi:10.1001/jama.286.21.2703 · Cited by 3,210
Delirium as a Predictor of Mortality in Mechanically Ventilated Patients in the Intensive Care Unit
Ely, E. W. (2004) · JAMA · doi:10.1001/jama.291.14.1753 · Cited by 3,073
Kress, J. P., Pohlman, A. S., O'Connor, M. F., & Hall, J. B. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005183422002 · Cited by 2,981
Introduction to the Analysis of Survival Data in the Presence of Competing Risks
Austin, P. C., Lee, D. S., & Fine, J. P. (2016) · Circulation · doi:10.1161/circulationaha.115.017719 · Cited by 2,653
Girard, T. D., Kress, J. P., Fuchs, B. D., Thomason, J. W., Schweickert, W. D., Pun, B. T., Taichman, D. B., Dunn, J. G., Pohlman, A. S., Kinniry, P. A., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60105-1 · Cited by 2,055
Cited by
Wilson, J. E., Mart, M. F., Cunningham, C., Shehabi, Y., Girard, T. D., MacLullich, A. M. J., Slooter, A. J. C., & Ely, E. W. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00223-4 · Cited by 1,200
Self-citationDelirium in critical illness: clinical manifestations, outcomes, and management
Stollings, J. L., Kotfis, K., Chanques, G., Pun, B. T., Pandharipande, P. P., & Ely, E. W. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06503-1 · Cited by 446
Aldecoa, C., Bettelli, G., Bilotta, F., Sanders, R. D., Aceto, P., Audisio, R., Cherubini, A., Cunningham, C., Dabrowski, W., Forookhi, A., et al. (2024) · European Journal of Anaesthesiology · doi:10.1097/eja.0000000000001876 · Cited by 356
Beloeil, H., Garot, M., Lebuffe, G., Gerbaud, A., Bila, J., Cuvillon, P., Dubout, E., Oger, S., Nadaud, J., Becret, A., et al. (2021) · Anesthesiology · doi:10.1097/aln.0000000000003725 · Cited by 333
Septic-Associated Encephalopathy: a Comprehensive Review
Mazeraud, A., Righy, C., Bouchereau, E., Benghanem, S., Bozza, F. A., & Sharshar, T. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00862-1 · Cited by 328
Analgesia and sedation in patients with ARDS
Chanques, G., Constantin, J.-M., Devlin, J. W., Ely, E. W., Fraser, G. L., Gélinas, C., Girard, T. D., Guérin, C., Jabaudon, M., Jaber, S., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06307-9 · Cited by 313
Self-citationDexmedetomidine or Propofol for Sedation in Mechanically Ventilated Adults with Sepsis
Hughes, C. G., Mailloux, P. T., Devlin, J. W., Swan, J. T., Sanders, R. D., Anzueto, A., Jackson, J. C., Hoskins, A. S., Pun, B. T., Orun, O. M., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2024922 · Cited by 287
Pham, T., Heunks, L., Bellani, G., Madotto, F., Aragao, I., Beduneau, G., Goligher, E. C., Grasselli, G., Laake, J. H., Mancebo, J., et al. (2023) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(22)00449-0 · Cited by 282
Self-citationRisk factors of postoperative delirium after cardiac surgery: a meta-analysis
Chen, H., Mo, L., Hu, H., Ou, Y., & Luo, J. (2021) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-021-01496-w · Cited by 265
Prevention and Management of Delirium in the Intensive Care Unit
Mart, M. F., Williams Roberson, S., Salas, B., Pandharipande, P. P., & Ely, E. W. (2021) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0040-1710572 · Cited by 257
Fordyce, C. B., Katz, J. N., Alviar, C. L., Arslanian-Engoren, C., Bohula, E. A., Geller, B. J., Hollenberg, S. M., Jentzer, J. C., Sims, D. B., Washam, J. B., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000909 · Cited by 116
ICU Survivorship—The Relationship of Delirium, Sedation, Dementia, and Acquired Weakness
Mart, M. F., Pun, B. T., Pandharipande, P., Jackson, J. C., & Ely, E. W. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005125 · Cited by 67
Zhou, Y., Yang, Y., Yi, L., Pan, M., Tang, W., & Duan, H. (2024) · Drug Design, Development and Therapy · doi:10.2147/dddt.s458013 · Cited by 13
Metadata
- Authors
- Shehabi, Y., Howe, B. D., Bellomo, R., Arabi, Y. M., Bailey, M., Bass, F. E., Bin Kadiman, S., McArthur, C. J., Murray, L., Reade, M. C., Seppelt, I. M., Takala, J., Wise, M. P., & Webb, S. A.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2019-06-27
- Volume
- 380
- Issue
- 26
- Pages
- 2506-2517
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2946554642
- Cited by
- 556
- References
- 43
- FWCI
- 83.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.